Drug Trial Radar · NCT02651220
Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris
Last checked: Nov 19, 2026Latest source record: Jun 23, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,001
Actual
Start
Nov 2015
Primary completion
Apr 2016
Study completion Oct 2016
Sponsor
- Lead sponsor
- Actavis Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 8, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of adapalene and benzoyl peroxide gel, 0.3%/2.5% (Actavis Laboratories UT, Inc.) to Epiduo® Forte (adapalene and benzoyl peroxide) gel 0.3%/2.5% (Galderma) in the treatment of Acne Vulgaris
Conditions
- Acne
Interventions
Epiduo® Forte GelDrug
Adapalene and Benzoyl Peroxide Gel, 0.3%/2.5% w/w
Adapalene and Benzoyl Peroxide GelDrug
Adapalene and Benzoyl Peroxide Gel, 0.3%/2.5% w/w
placebo gelDrug
vehicle used as placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline to Week 12 in the Number of Inflamed Lesions.Time frame: 12 weeks
- Percent Change From Baseline to Week 12 in the Number of Non-inflamed Lesions.Time frame: 12 weeks
Locations
20 sites in 2 countries. Site status is shown where the registry gives one.
Site 103
Mesa, Arizona
Site 109
Tucson, Arizona
Site 112
Anaheim, California
Site 110
Long Beach, California
Site 111
Los Angeles, California
Site 104
San Diego, California
Site 113
West Covina, California
Site 101
Brandon, Florida
Site 119
Jacksonville, Florida
Site 114
Miami, Florida
Site 115
Miami, Florida
Site 116
Miramar, Florida
Site 102
Arlington Heights, Illinois
Site 105
Carmel, Indiana
Site 120
New Albany, Indiana
Site 107
Henderson, Nevada
Site 106
High Point, North Carolina
Site 108
Rhinelander, Wisconsin
Site 117
Belize City, Belize
Site 118
Belize City, Belize
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.